RecruitingPhase 2NCT06866275

Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)

Studying Interatrial communication

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Orange County
Principal Investigator
Aram Kim, MD, M.D
Thompson Autism and Neurodevelopmental Center, Children's Hospital of Orange County
Intervention
KZ101(drug)
Enrollment
45 target
Eligibility
5-14 years · MALE
Timeline
2025 – 2028

Study locations (3)

Collaborators

Kuzani Pharmaceuticals, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06866275 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials